obesity drug news today glp-1 2025 sep 30 Agonists Market Report 2025-2033, By Product, Molecule, and Geo A New Medicare Option for

Emerging evidence suggests GLP-1RAs may help in: Alzheimer Disease Reduced neuroinflammation Improved neuronal survival Potential slowing of cognitive decline Parkinson Disease Neuroprotective effects Reduced oxidative stress Improved neuronal signaling This area may redefine future neuroendocrine therapeutics

Federal oversight of GLP-1-related claims on dietary supplements and food labels is minimal, despite confusion among some consumers

[12] Research has shown that the impact of skin aging can have a significant psychological impact, including the development of social anxiety and isolation

Role of GLP-1 Agonists and SGLT-2 on Diabetes and Kidney Disease Post Liver Transplant The emergence of Glucagon-like peptide-1 receptor (GLP-1) agonists and Sodium-glucose cotransporter-2 (SGLT-2) inhibitors as glucose-lowering therapies has opened new therapeutic avenues for managing patients with diabetic kidney disease

Nutrition and Hydration Challenges with Weight Loss Injections Emerging research suggests that patients on GLP-1 weight loss injections often experience shifts in their macronutrient intake (macronutrients are your carbs, protein, and fat), particularly an increase in carbohydrate consumption relative to protein